Article Text
PDF
Abstract
Genomic testing has been available for neurological conditions for decades. However, in recent years, there has been a significant change in its availability, range and cost, as well as improvements in the technology and knowledge that underpin how the genome is interrogated. Neurologists can encounter a wide range of genetic conditions, and so their understanding of genomic testing is fundamental to modern clinical practice.
- genetics
- neurogenetics
Data availability statement
Data sharing not applicable as no datasets generated and/or analysed for this study.
Statistics from Altmetric.com
Data availability statement
Data sharing not applicable as no datasets generated and/or analysed for this study.
Footnotes
Contributors VJ wrote and revised the article. RI and AW reviewed and revised the article.
Funding The authors have not declared a specific grant for this research from any funding agency in the public, commercial or not-for-profit sectors.
Competing interests None declared.
Provenance and peer review Commissioned. Externally peer reviewed by Ed Newman, Glasgow, UK, and Helen Grote, London, UK.
Read the full text or download the PDF:
Other content recommended for you
- Rare disease genomic testing in the UK and Ireland: promoting timely and equitable access
- Use of whole genome sequencing to determine genetic basis of suspected mitochondrial disorders: cohort study
- Genetic testing and reproductive choice in neurological disorders
- Cardiovascular genetics: the role of genetic testing in diagnosis and management of patients with hypertrophic cardiomyopathy
- Genomics for paediatricians: promises and pitfalls
- Lessons and pitfalls of whole genome sequencing
- Genetic diagnosis of Duchenne and Becker muscular dystrophy through mRNA analysis: new splicing events
- Modern genomic techniques in the identification of genetic causes of cardiomyopathy
- Genetic testing in dementia
- Research needs for birth defect prevention and control in China in the genomic screening era